Brain stress system response after morphine-conditioned place preference

International Journal of Neuropsychopharmacology

Volumn 16, Issue 9, 2013, Pages 1999-2011

  García Carmona, Juan Antonio ^a   Milanés, María Victoria ^a   Laorden, María Luisa ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Brain stress system; conditioned place preference; corticotropin releasing factor; pCREB

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; ENVIRONMENTAL FACTOR; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PARAVENTRICULAR THALAMIC NUCLEUS; PLACE PREFERENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; REINFORCEMENT; SOLITARY TRACT NUCLEUS; STRESS; STRIA TERMINALIS; VENTRAL TEGMENTUM;

ADRENOCORTICOTROPIC HORMONE; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CONDITIONING (PSYCHOLOGY); CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; CUES; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; MICE; MORPHINE; NEURONS; PHOSPHORYLATION; REINFORCEMENT (PSYCHOLOGY); STRESS, PHYSIOLOGICAL;

EID: 84883440884     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145713000588     Document Type: Article

References (51)

1. Almela P, Navarro-Zaragoza J, García-Carmona JA, Mora L, Hidalgo MV, Laorden ML (2012) Role of corticotropinreleasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc) PLoS ONE 7:e47089
2. Barcia C, Sánchez A, Fernández-Villalba E, Bautista V, Poza M, Fernández-Barreiro A, Hirsch E, Herrero M-T (2004) Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia 46:402-409
3. Bardo MT, Rowlett JK, Harris MJ (1995) Conditioned place preference using opiate and stimulant drugs: a meta-Analysis. Neurosci Biobehav Rev 19:39-51
4. Berhow MT, Russel DS, Terwilliger RZ, Beitner-Johnson D, Self DW, Lindsay RM, Nestler EJ (1995) Influence of neurotrophic factors on morphine - and cocaine-induced biochemical changes in the mesolimbic dopamine system Neurosci 68:969-979
5. Bornstein SR, Engeland WC, Ehrhart-Bornstein ME, Herman JP (2008) Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab 19:175-180
6. Brielmaier J, McDonald CG, Smith RF (2012) Effects of acute stress on acquisition of nicotine conditioned place preference in adolescent rats: a role for corticotopin-releasing factor 1 receptors. Psychopharmacology 219:73-82
7. Chen Y-W, Rada PV, Bützler BP, Leibowitz SF, Hoebel BG (2012) Corticotropin-releasing factor in the nucleus accumbens shell induces swim depression, anxiety, and anhedonia along with changes in local dopamine/acetylcholine balance. Neurosci 206:155-166
8. Choi DC, Furai AR, Evanson NK, Ostrander MM, Ulrich-Lai YM, Herman JP (2007) Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitaryadrenal axis activity: implications for the integration of limbic inputs. J Neurosci 27:2025-2034
9. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000) Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403:430-434
10. Di Chiara G, North AR (1992) Neurobiology of opiate abuse. Trends Pharmacol Sci 13:185-193
11. Everitt BJ, Wolf ME (2002) Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22:3312-3320
12. Fatseas M, Denis C, Massida Z, Verger M, Franques-Reneric P, Auriacombe M (2011) Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals. Biol Psychiatry 70:720-727
13. Fox HC, Bergquist KL, Hong KI, Sinha R (2007) Stress-induced and alcohol cue-induced craving in recently abstinent alcohol-dependent individuals. Alcohol Clin Exp Res 31:395-403
14. Goeders NE, Guerin GF (2000) Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine selfadministration in rats. Neurophsychopharmacology 23:577-586
15. González-Cuello A, Mora L, Hidalgo JM, Meca N, Lasheras C, Milanés MV, Laorden ML (2010) Enhanced tyrosine hydroxylase phosphorylation in the nucleus accumbens and nucleus tractus solitarius-A2 cell group after morphine-conditioned place preference. Naunyn-Schmiedeberg's Arch Pharmacol 382:525-534
16. Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162:1403-1413
17. Kasagi Y, Horiba N, Sakai K, Fukuda Y, Suda T (2002) Involvement of cAMP-response element binding protein in corticotropin-releasing factor (CRF)-induced downregulation of CRF receptor 1 gene expression in rat anterior pituitary cells. J Neuroendocrinol 14:587-592
18. Koob GF (1999) Corticotropin-releasing factor, norepinephrine and stress. Biol Psychiatry 46:1167-1180
19. Koob GF, Le Moal M (2008) Addiction and the rain antireward system. Ann Rev Physiol 59:29-53
20. Koob GF, Sanna PP, Bloom FE (1998) Neuroscience of addiction. Neuron 21:467-476
21. Kreibich AS, Briand L, Cleck JN, Ecke L, Rice KC, Blendy JA (2009) Stress-induced potentiation of cocaine reward: a role for CRFR1 and CREB. Neuropsychopharmacology 34:2609-2617
22. Lim MM, Liu Y, Ryabinin AE, Bai Y,Wang Z, Young LJ (2007) CRF receptors in the nucleus accumbens modulate partner preference in prairie voles. Horm Behav 51:508-515
23. Ma YY, Meng L, Guo CHY, Han JS, Lee D, Cui CL (2009) Dose- and time-dependent, context-induced elevation of dopamine and its metabolites in the nucleus accumbens of morphine-induced CPP rats. Behav Brain Res 204:192-199
24. Manzanedo C, Aguilar MA, Rodriguez-Arias M, Miñarro J (2001) Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav Brain Res 121:189-197
25. Merchenthaler I (1984) Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides 5:53-69
26. Merchenthaler I, Vigh S, Petrusz P, Schally AV (1982) Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am J Anat 165:385-396
27. Moaddab M, Haghparast A, Hassanpour-Ezatti M (2009) Effects of reversible inactivation of the ventral tegmental area on the acquisition and expression of morphine-induced conditioned place preference in the rat. Behav Brain Res 198:466-471
28. Navarro-Zaragoza J, Núñez C, Laorden ML, Milanés MV (2010) Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal. Mol Pharmacol 77:864-873
29. Navarro-Zaragoza J, Núñez C, Ruiz-Medina J, Laorden ML, Valverde O, Milanés MV (2011) CRF(2) mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats. Br J Pharmacol 162:851-862
30. Nestler EJ (2004) Molecular mechanisms of drug addiction. Neuropharmacology 47:24-32
31. O'Brien CP, Childress AR, McLellan AT, Ehrman RN (1992) Classical conditioning in drug-dependent humans. Ann NY Acad Sci 654:400-415
32. O'Brien CP, Childress AR, Ehrman RN, Robbins SJ (1998) Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacology 12:15-22
33. Olson VG, Heusner CL, Bland RJ (2006) Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward. Science 311:1017-1020
34. Piaza PV, Le Moal ML (1996) Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36:359-378
35. Rodaros D, Caruana DA, Amir S, Stewart J (2007) Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neuroscience 150:8-13
36. See RE (2002) Neural substrates of conditioned-cued relapse to drug-seeking behavior. Pharmacol Biochem Behav 71:517-529
37. Sinha R (2001) How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) 158:343-359
38. Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ (2003) Hypothalamic-pituitary-Adrenal axis and sympatho-Adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology 170:62-72
39. Sinha R, García M, Paliwal P, Kreek MJ, Rounsaville BJ (2006) Stress induced cocaine craving and hypothalamic-pituitary-Adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63:324-331
40. Stinus L, Cador M, Zorrilla EP, Koob GF (2005) Buprenorphine and CRF1R antagonists block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology 30:90-98
41. Tilders FJ, Berkenbosch F, Vermes I, Linton EA, Smelek PG (1985) Role of epinephrine and vasopressin the control of the pituitary-Adrenal response to stress. Fed Proc 44:155-168
42. Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613-672
43. Tzschentke TM (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12:227-462
44. Tzschentke TM, Schmidt WJ (1995) N-methyl-D-Aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci Lett 193:37-40
45. Valverde O, Fournie-Zaluski MC, Roques BP, Maldonado R (1996) The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats. Psychopharmacology 123:119-126
46. Van der Kooy D (1987) Place conditioning: a simple and effective method for assessing the motivational properties of drugs. In: Methods of assessing the reinforcing properties of abused drugs (Bozarth MA ed), pp 229-240 New York: Springer
47. Ventura R, Alcaro A, Puglisi-Allegra S (2005) Prefrontal cortical norepinephrine release is critical for morphine-induced reward, reinstatement and dopamine release in the nucleus accumbens. Cereb Cortex 15:1877-1886
48. Waldrop AE, Price KL, Desantis SM, Simpson AN, Back SE, McRae AL, Spratt EG, Kreek MJ, Brady KT (2010) Community-dwelling cocaine-dependent men and women respond differently to social stressors vs cocaine cues. Psychoneuroendocrinology 35:798-806
49. Wanat MJ, Hopf FW, Stuber GD, Phillips PE, Bonci A (2008) Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J Physiol 586:2157-2170
50. Weinshenker D, Schroeder JP (2007) There and back again: a tale of norepinephrine and drug addiction. Neuorpsychopharmacology 32:1433-1451
51. Zarrindast MR, Ebrahimi-Ghiri M, Rostami P, Rezayof A (2007) Repeated pre-exposure to morphine into the ventral pallidum enhances morphine-induced place preference: involvement of dopaminergic and opioidergic mechanisms. Behav Brain Res 181:35-41.